Skip to content

Adherence to the "best medical treatment (BMT)" of patients of a neurovascular outpatient clinic

Adherence to the "best medical treatment (BMT)" of patients of a neurovascular outpatient clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016410
Enrollment
200
Registered
2019-04-02
Start date
2019-04-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I65.2 I65.0 I65.1 I66.0 I66.1 I66.2 I66.3 I66.4 I66.8 I65.8

Interventions

Group 1: Patients with an extra- or intracranial stenosis of one or more brain supplying arteries are educated via a detailed and structured interview about the importance of BMT. Subsequently, the ad

Sponsors

Klinik und Poliklinik für Neurologie, Universitätsklinikum Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years 2. an at least mild-to-moderate (20-40% NASCET) Stenosis of one ore more extracranial brain supplying artery OR 3. any stenosis of an intracranial brain supplying artery OR 4. a revascularisation (either Operation or stenting) of an extracranial brain supplying artery in the past 5. written and informed consent of the participant

Exclusion criteria

Exclusion criteria: pregnant or breast-feeding patients

Design outcomes

Primary

MeasureTime frame
1. It shall be examined whether there is an association between the adherence to the "best medical therapy" and the cardio-vascular risk (assessment of cardio-vascular events as well as of the following surrogate parameters: high-sensitive CRP, total-, HDL- and LDL cholesterol, HbA1c, and sonographic progression of stenosis).

Secondary

MeasureTime frame
1. To identify factors that impair the implementation of BMT in a real world Setting. 2. The self-perception of patients concerning their vascular disease shall be examined. 3. To assess the Impact of BMT on cognition.

Countries

Germany

Contacts

Public ContactJohann Pelz

Klinik und Poliklinik für Neurologie, Universitätsklinikum Leipzig

johann.pelz@medizin.uni-leipzig.de03419724200

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026